Kelan Thomas

2.5k total citations · 1 hit paper
26 papers, 1.8k citations indexed

About

Kelan Thomas is a scholar working on Clinical Psychology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kelan Thomas has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Clinical Psychology, 6 papers in Psychiatry and Mental health and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kelan Thomas's work include Psychedelics and Drug Studies (8 papers), Forensic Toxicology and Drug Analysis (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Kelan Thomas is often cited by papers focused on Psychedelics and Drug Studies (8 papers), Forensic Toxicology and Drug Analysis (5 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Kelan Thomas collaborates with scholars based in United States, Netherlands and Denmark. Kelan Thomas's co-authors include Michael J. Keiser, Brian K. Shoichet, Jérôme Hert, Niels Jensen, Atheir I. Abbas, Thuy Tran, Christian Laggner, Richard A. Glennon, Sandra J. Hufeisen and Bryan L. Roth and has published in prestigious journals such as Nature, Scientific Reports and Pharmacology & Therapeutics.

In The Last Decade

Kelan Thomas

22 papers receiving 1.7k citations

Hit Papers

Predicting new molecular targets for known drugs 2009 2026 2014 2020 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Predicting new molecular targets for known drugs
    2009 1.3k citations Michael J. Keiser, Vincent Setola et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelan Thomas United States 12 920 831 303 274 240 26 1.8k
Niels Jensen United States 19 1.4k 1.5× 898 1.1× 404 1.3× 175 0.6× 297 1.2× 36 2.5k
Thuy Tran United States 13 1.1k 1.2× 879 1.1× 324 1.1× 96 0.4× 198 0.8× 21 1.9k
Sandra J. Hufeisen United States 13 1.7k 1.8× 904 1.1× 601 2.0× 357 1.3× 281 1.2× 16 3.4k
Catia Lambertucci Italy 29 1.5k 1.6× 252 0.3× 483 1.6× 41 0.1× 761 3.2× 113 3.0k
Konstantina G. Yiannopoulou Greece 11 347 0.4× 195 0.2× 396 1.3× 81 0.3× 84 0.3× 29 1.6k
Fawaz Alasmari Saudi Arabia 26 601 0.7× 92 0.1× 197 0.7× 37 0.1× 323 1.3× 167 2.2k
Qingchun Zhao China 27 969 1.1× 92 0.1× 266 0.9× 29 0.1× 201 0.8× 131 2.4k
R. Anand India 17 348 0.4× 161 0.2× 469 1.5× 28 0.1× 109 0.5× 41 2.0k
Aaron Ritter United States 15 556 0.6× 383 0.5× 630 2.1× 32 0.1× 90 0.4× 44 2.4k

Countries citing papers authored by Kelan Thomas

Since Specialization
Citations

This map shows the geographic impact of Kelan Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelan Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelan Thomas more than expected).

Fields of papers citing papers by Kelan Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelan Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelan Thomas. The network helps show where Kelan Thomas may publish in the future.

Co-authorship network of co-authors of Kelan Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Kelan Thomas. A scholar is included among the top collaborators of Kelan Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelan Thomas. Kelan Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Kelan. (2024). Toxicology and Pharmacological Interactions of Classic Psychedelics. Current topics in behavioral neurosciences.
2.
Thomas, Kelan. (2023). Pharmacists and psychedelic medicine. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(10). 1082–1083.
3.
Thomas, Kelan, et al.. (2023). Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics. Journal of Psychoactive Drugs. 56(2). 206–210. 1 indexed citations
4.
Thomas, Kelan, et al.. (2022). Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology. 239(6). 1945–1976. 45 indexed citations
5.
Malcolm, Benjamin & Kelan Thomas. (2021). Serotonin toxicity of serotonergic psychedelics. Psychopharmacology. 239(6). 1881–1891. 75 indexed citations
6.
Cohen, Isaac, Tigran Makunts, Ruben Abagyan, & Kelan Thomas. (2021). Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database. Scientific Reports. 11(1). 5997–5997. 16 indexed citations
7.
Thomas, Kelan & Andrew J. Muzyk. (2018). Surveys of substance use disorders education in US pharmacy programs. Mental Health Clinician. 8(1). 14–17. 22 indexed citations
8.
Thomas, Kelan, et al.. (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. Journal of Psychoactive Drugs. 49(5). 446–455. 52 indexed citations
9.
Muzyk, Andrew J., et al.. (2017). Substance use Education in US Schools of Pharmacy: A Systematic Review of the Literature. Substance Abuse. 38(4). 455–463. 20 indexed citations
10.
Dopheide, Julie A., Jolene R. Bostwick, Lisa W. Goldstone, et al.. (2017). Curriculum in Psychiatry and Neurology for Pharmacy Programs. American Journal of Pharmaceutical Education. 81(7). 5925–5925. 26 indexed citations
11.
Thomas, Kelan, et al.. (2017). Concomitant Calcium Channel Blocker and Antipsychotic Therapy in Patients with Schizophrenia: Efficacy Analysis of the Catie-Sz Phase 1 Data. Annals of Clinical Psychiatry. 29(4). 1–11. 5 indexed citations
12.
Thomas, Kelan, et al.. (2016). Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accident Analysis & Prevention. 92. 240–244. 10 indexed citations
13.
Doroudgar, Shadi, et al.. (2016). Driving performance comparing older versus younger drivers. Traffic Injury Prevention. 18(1). 41–46. 81 indexed citations
14.
Nguyen, Linda, Kelan Thomas, Brandon Lucke‐Wold, et al.. (2016). Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics. 159. 1–22. 99 indexed citations
15.
Bly, Michael J., Jeffrey R. Bishop, Kelan Thomas, & Vicki L. Ellingrod. (2013). P-glycoprotein (PGP) Polymorphisms and Sexual Dysfunction in Female Patients With Depression and SSRI-Associated Sexual Side Effects. Journal of Sex & Marital Therapy. 39(3). 280–288. 18 indexed citations
16.
English, Brett A., et al.. (2013). Use of Translational Pharmacodynamic Biomarkers in Early-Phase Clinical Studies for Schizophrenia. Biomarkers in Medicine. 8(1). 29–49. 10 indexed citations
17.
Thomas, Kelan, Vicki L. Ellingrod, Jeffrey R. Bishop, & Michael J. Keiser. (2010). A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach.. PubMed. 43(1). 11–22. 6 indexed citations
18.
Keiser, Michael J., Vincent Setola, John J. Irwin, et al.. (2009). Predicting new molecular targets for known drugs. Nature. 462(7270). 175–181. 1251 indexed citations breakdown →
19.
Thomas, Kelan & Vicki L. Ellingrod. (2009). Pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(7). 822–831. 22 indexed citations
20.
Thomas, Kelan, Stephanie Cosner Berzin, & Edward Cohen. (2005). Fidelity of Family Group Decision-Making: A content analysis of family conference and case plans in a randomized treatment study.. 19(4). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Jensen Breakdown of academic impact, for papers by Thuy Tran Breakdown of academic impact, for papers by Sandra J. Hufeisen Breakdown of academic impact, for papers by Catia Lambertucci Breakdown of academic impact, for papers by Konstantina G. Yiannopoulou Breakdown of academic impact, for papers by Fawaz Alasmari Breakdown of academic impact, for papers by Qingchun Zhao Breakdown of academic impact, for papers by R. Anand Breakdown of academic impact, for papers by Aaron Ritter
Rankless by CCL
2026